I hope they don’t waste too much money on H2. Smart money now realize it’s feasibility is fast diminishing with the superiority of Li being demonstrated globally.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%